Janssen Cilag Pharmaceutica S.A.C.I., Greece clinical trials
A country office of Johnson & Johnson
The registry lists 6 studies whose lead sponsor is Janssen Cilag Pharmaceutica S.A.C.I., Greece. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 26, 2012.
Registry sponsor names on this page
- Janssen Cilag Pharmaceutica S.A.C.I., Greece6 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Johnson & Johnson studies →
- A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's DiseaseCompletedNCT00297362
Sponsor listed in the registry: Janssen Cilag Pharmaceutica S.A.C.I., Greece
- An Observational Study of the Safety of Topiramate in Adults and Children With EpilepsyCompletedNCT00297323
Sponsor listed in the registry: Janssen Cilag Pharmaceutica S.A.C.I., Greece
- An Observational Study Evaluating the Safety of Topiramate for the Prevention of MigraineCompletedNCT00297336
Sponsor listed in the registry: Janssen Cilag Pharmaceutica S.A.C.I., Greece
- A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With SeizuresCompletedNCT00297349
Sponsor listed in the registry: Janssen Cilag Pharmaceutica S.A.C.I., Greece
- A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)CompletedNCT00216489Phase 4
Sponsor listed in the registry: Janssen Cilag Pharmaceutica S.A.C.I., Greece
- Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.CompletedNCT00216450Phase 4
Sponsor listed in the registry: Janssen Cilag Pharmaceutica S.A.C.I., Greece